Pharmacokinetics of imipenem-cilastatin in neonates.
Imipenem and its renal dehydropeptidase I inhibitor, cilastatin, were coadministered intravenously in a 1:1 ratio to 30 newborns. Five infants each received single doses of 10, 15, or 20 mg/kg of both drugs. Concentrations in plasma were proportional to the administered dose, and cilastatin achieved...
שמור ב:
| הוצא לאור ב: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Microbiology (ASM)
1985
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180068/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3859242/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.27.4.431 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|